domingo, 27 de noviembre de 2016

Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antib... - PubMed - NCBI

Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antib... - PubMed - NCBI
 2016 Feb;12(2):180-1. doi: 10.1200/JOP.2015.007898. Epub 2015 Oct 6.

Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015 Summary.

PMID:
 
26443838
 
DOI:
 
10.1200/JOP.2015.007898
[PubMed - indexed for MEDLINE]

Public Health Genomics Knowledge Base (v1.2)
Genomics & Health Impact Update banner with DNA in background


Last Updated: Nov 09, 2016
CDC Resources with and image of DNA
Seletced Insights & Reviews with various images of researchers in labortory environments
Epidemiology with an image of a crowd of people with a double helix
Translational Research with two images of people talking to a genetic counselor and an image of a hand with wrapped sequecing around it
Evidence Synthesis with an image of sequencing and a double helix
Practice & Implementation with images of people taking to a doctor and a nurse examining a child

Relevant Resources

No hay comentarios:

Publicar un comentario en la entrada